Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter“Fujirebio”) today announced that ...

Key factors to consider in choosing a CDMO The primary focus of most entities choosing a CDMO, Lewis says, is narrowed down to three main considerations: speed, quality, and cost. And while it can ...

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

The next-generation personalized nutrition market is projected to expand at a CAGR of 15-17% between 2025 and 2030. Key ...

Nine fintech-focused chief marketing officers (CMOs) have been named among the most influential and purposeful marketers in Asia-Pacific (APAC), recognized by Campaign Asia-Pacific and DoubleVerify ...

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in ...

Strides Pharmaceuticals has introduced ‘OneSource,’ an independent Specialty Pharma Contract Development and Manufacturing Organization (CDMO), with plans to go public within the next 12 to 15 ...

In the short term, communities can receive income support through land rehabilitation and forest work. Landscape programs can be scaled up to create jobs, support livelihoods and market access, and ...